3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
11
Rectal Neoplasms
5
Colorectal Neoplasms
5
Stomach Neoplasms
3
Neoplasm Metastasis
3
Nasopharyngeal Carcinoma
3
Carcinoma, Non-Small-Cell Lung
3
Triple Negative Breast Neoplasms
2
Lung Neoplasms
2
Spinocerebellar Degenerations
1
Solid Tumor
1
Resectable NSCLC
1
Recurrence
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Meningeal Carcinomatosis
1
MSI-H
1
Lymphoma, T-Cell, Peripheral
1
HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Interventions
Specimen Handling
4
Radiotherapy
4
Radiation
4
Nivolumab
4
pembrolizumab
3
Magnetic Resonance Spectroscopy
3
Ipilimumab
3
Doxorubicin
3
CTLA-4 Antigen
3
Biopsy
3
talimogene laherparepvec
1
peposertib
1
pazopanib
1
liposomal doxorubicin
1
fludarabine
1
cabozantinib
1
aldesleukin
1
X-Rays
1
Trabectedin
1
Ifosfamide
1
Histamine H2 Antagonists
1
Famotidine
1
Dactinomycin
1
Cyclophosphamide
1
BO-112
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Histiocytoma, Malignant Fibrous
×
sintilimab
×
90 days
×
Clear all
No trials found.